Agenus | Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 266K 30K 2025-03
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 1.16B 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 66.45M 53K 2025-09
CSL USD 576M 19M 2024-12
Dynavax Technologies USD 117.23M 117.11M 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Incyte USD 196.13M 2.01M 2025-09
Intrexon USD 0 0 2024-06
J&J USD 2.41B 584K 2025-09
Jiangsu Hengrui CNY 6.64B 0 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.26M 62.63M 2025-09
Merck EUR 434.78M 130.22M 2025-06
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Novavax USD 1.62M 211K 2024-09
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 78.67M 73K 2025-09


Agenus Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.